nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—ALOX5—atherosclerosis	0.781	1	CbGaD
Masoprocol—CYP2J2—artery—atherosclerosis	0.00604	0.15	CbGeAlD
Masoprocol—IGF1R—Pitavastatin—Rosuvastatin—atherosclerosis	0.00524	1	CbGdCrCtD
Masoprocol—CYP2J2—blood vessel—atherosclerosis	0.0047	0.117	CbGeAlD
Masoprocol—IGF1R—connective tissue—atherosclerosis	0.00356	0.0887	CbGeAlD
Masoprocol—LTB4R—adipose tissue—atherosclerosis	0.00331	0.0824	CbGeAlD
Masoprocol—IGF1R—cardiovascular system—atherosclerosis	0.00309	0.0771	CbGeAlD
Masoprocol—IGF1R—adipose tissue—atherosclerosis	0.00273	0.068	CbGeAlD
Masoprocol—LTB4R—liver—atherosclerosis	0.00232	0.0578	CbGeAlD
Masoprocol—CYP2J2—cardiovascular system—atherosclerosis	0.0021	0.0523	CbGeAlD
Masoprocol—IGF1R—liver—atherosclerosis	0.00191	0.0477	CbGeAlD
Masoprocol—ALOX5—connective tissue—atherosclerosis	0.0019	0.0473	CbGeAlD
Masoprocol—ALOX5—cardiovascular system—atherosclerosis	0.00165	0.0412	CbGeAlD
Masoprocol—ALOX5—adipose tissue—atherosclerosis	0.00146	0.0363	CbGeAlD
Masoprocol—CYP19A1—connective tissue—atherosclerosis	0.00131	0.0327	CbGeAlD
Masoprocol—CYP2J2—liver—atherosclerosis	0.0013	0.0323	CbGeAlD
Masoprocol—ALOX5—liver—atherosclerosis	0.00102	0.0255	CbGeAlD
Masoprocol—CYP19A1—adipose tissue—atherosclerosis	0.00101	0.0251	CbGeAlD
Masoprocol—CYP19A1—liver—atherosclerosis	0.000707	0.0176	CbGeAlD
Masoprocol—ALOX5—Metabolism—APOA2—atherosclerosis	7.22e-05	0.000415	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALOX15—atherosclerosis	7.22e-05	0.000415	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.2e-05	0.000414	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR2—atherosclerosis	7.18e-05	0.000412	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EDNRA—atherosclerosis	7.18e-05	0.000412	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CYBA—atherosclerosis	7.15e-05	0.000411	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLA2G1B—atherosclerosis	7.13e-05	0.00041	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCG5—atherosclerosis	7.13e-05	0.00041	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.12e-05	0.000409	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	7.1e-05	0.000408	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CG—atherosclerosis	7.08e-05	0.000407	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.05e-05	0.000405	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLAT—atherosclerosis	6.99e-05	0.000402	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VWF—atherosclerosis	6.99e-05	0.000402	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GHRL—atherosclerosis	6.99e-05	0.000402	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PARP1—atherosclerosis	6.99e-05	0.000402	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.99e-05	0.000402	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.97e-05	0.000401	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOC3—atherosclerosis	6.95e-05	0.000399	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LDLR—atherosclerosis	6.91e-05	0.000397	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LPA—atherosclerosis	6.89e-05	0.000396	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALOX5—atherosclerosis	6.89e-05	0.000396	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLTP—atherosclerosis	6.83e-05	0.000393	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL3—atherosclerosis	6.75e-05	0.000388	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—F2—atherosclerosis	6.72e-05	0.000386	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BGN—atherosclerosis	6.67e-05	0.000383	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.62e-05	0.000381	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOA5—atherosclerosis	6.6e-05	0.00038	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NCF1—atherosclerosis	6.46e-05	0.000371	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CG—atherosclerosis	6.43e-05	0.000369	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.41e-05	0.000369	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.36e-05	0.000366	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLA2G1B—atherosclerosis	6.36e-05	0.000365	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.33e-05	0.000364	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.29e-05	0.000362	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.29e-05	0.000361	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.25e-05	0.000359	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.23e-05	0.000358	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.21e-05	0.000357	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NAMPT—atherosclerosis	6.18e-05	0.000355	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.14e-05	0.000353	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—LIPC—atherosclerosis	6.14e-05	0.000353	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KNG1—atherosclerosis	6.14e-05	0.000353	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.11e-05	0.000351	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGTR1—atherosclerosis	6.1e-05	0.000351	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EDNRA—atherosclerosis	6.1e-05	0.000351	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR2—atherosclerosis	6.1e-05	0.000351	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOC3—atherosclerosis	6.1e-05	0.000351	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CYBA—atherosclerosis	6.08e-05	0.000349	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—LDLR—atherosclerosis	6.06e-05	0.000349	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL2—atherosclerosis	5.99e-05	0.000344	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLAT—atherosclerosis	5.95e-05	0.000342	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PARP1—atherosclerosis	5.95e-05	0.000342	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLG—atherosclerosis	5.95e-05	0.000342	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GHRL—atherosclerosis	5.95e-05	0.000342	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LTA4H—atherosclerosis	5.92e-05	0.00034	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCG8—atherosclerosis	5.92e-05	0.00034	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CETP—atherosclerosis	5.92e-05	0.00034	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.85e-05	0.000336	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SCARB1—atherosclerosis	5.67e-05	0.000326	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.67e-05	0.000326	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SOCS3—atherosclerosis	5.63e-05	0.000324	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	5.56e-05	0.00032	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.52e-05	0.000317	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.52e-05	0.000317	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NAMPT—atherosclerosis	5.51e-05	0.000316	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.47e-05	0.000315	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LIPC—atherosclerosis	5.47e-05	0.000314	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP3—atherosclerosis	5.44e-05	0.000313	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOC3—atherosclerosis	5.44e-05	0.000313	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF2—atherosclerosis	5.42e-05	0.000311	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LDLR—atherosclerosis	5.41e-05	0.000311	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMGCR—atherosclerosis	5.36e-05	0.000308	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CETP—atherosclerosis	5.28e-05	0.000303	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOB—atherosclerosis	5.26e-05	0.000302	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KNG1—atherosclerosis	5.22e-05	0.0003	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL8—atherosclerosis	5.21e-05	0.0003	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGTR1—atherosclerosis	5.19e-05	0.000298	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EDN1—atherosclerosis	5.17e-05	0.000297	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL5—atherosclerosis	5.13e-05	0.000295	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLG—atherosclerosis	5.06e-05	0.000291	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SCARB1—atherosclerosis	5.06e-05	0.000291	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	5.05e-05	0.00029	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LPL—atherosclerosis	5.02e-05	0.000288	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.92e-05	0.000283	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.92e-05	0.000283	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PRKCG—atherosclerosis	4.88e-05	0.00028	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.83e-05	0.000278	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SOCS3—atherosclerosis	4.79e-05	0.000275	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCA1—atherosclerosis	4.77e-05	0.000274	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMGCR—atherosclerosis	4.77e-05	0.000274	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SPP1—atherosclerosis	4.75e-05	0.000273	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL8—atherosclerosis	4.73e-05	0.000272	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCG1—atherosclerosis	4.68e-05	0.000269	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP3—atherosclerosis	4.63e-05	0.000266	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF2—atherosclerosis	4.6e-05	0.000265	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOB—atherosclerosis	4.47e-05	0.000257	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LCAT—atherosclerosis	4.4e-05	0.000253	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—FABP4—atherosclerosis	4.4e-05	0.000253	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EDN1—atherosclerosis	4.4e-05	0.000253	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDGFB—atherosclerosis	4.4e-05	0.000253	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL5—atherosclerosis	4.37e-05	0.000251	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOA4—atherosclerosis	4.32e-05	0.000248	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.31e-05	0.000247	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGT—atherosclerosis	4.29e-05	0.000247	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LPL—atherosclerosis	4.27e-05	0.000245	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCA1—atherosclerosis	4.26e-05	0.000245	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP7A1—atherosclerosis	4.25e-05	0.000244	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LEP—atherosclerosis	4.21e-05	0.000242	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—atherosclerosis	4.21e-05	0.000242	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CAV1—atherosclerosis	4.17e-05	0.00024	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOA1—atherosclerosis	4.16e-05	0.000239	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PRKCG—atherosclerosis	4.15e-05	0.000238	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—atherosclerosis	4.1e-05	0.000235	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.05e-05	0.000232	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SPP1—atherosclerosis	4.04e-05	0.000232	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ESR1—atherosclerosis	4.02e-05	0.000231	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—F2—atherosclerosis	3.97e-05	0.000228	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP27A1—atherosclerosis	3.92e-05	0.000225	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOB—atherosclerosis	3.92e-05	0.000225	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.86e-05	0.000222	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—atherosclerosis	3.82e-05	0.000219	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CG—atherosclerosis	3.8e-05	0.000218	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.77e-05	0.000217	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—LPL—atherosclerosis	3.75e-05	0.000215	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDGFB—atherosclerosis	3.74e-05	0.000215	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOA2—atherosclerosis	3.72e-05	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLA2G2A—atherosclerosis	3.72e-05	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALOX15—atherosclerosis	3.72e-05	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALOX5AP—atherosclerosis	3.72e-05	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCG5—atherosclerosis	3.67e-05	0.000211	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.67e-05	0.000211	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—atherosclerosis	3.66e-05	0.00021	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGT—atherosclerosis	3.65e-05	0.00021	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—atherosclerosis	3.65e-05	0.00021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK3—atherosclerosis	3.64e-05	0.000209	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INS—atherosclerosis	3.59e-05	0.000207	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—atherosclerosis	3.58e-05	0.000206	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LEP—atherosclerosis	3.58e-05	0.000206	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CD36—atherosclerosis	3.56e-05	0.000205	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LPA—atherosclerosis	3.55e-05	0.000204	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CAV1—atherosclerosis	3.54e-05	0.000204	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOA1—atherosclerosis	3.54e-05	0.000203	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL2—atherosclerosis	3.54e-05	0.000203	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOB—atherosclerosis	3.5e-05	0.000201	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—atherosclerosis	3.48e-05	0.0002	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BGN—atherosclerosis	3.44e-05	0.000198	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ESR1—atherosclerosis	3.42e-05	0.000196	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.41e-05	0.000196	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—atherosclerosis	3.4e-05	0.000196	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOA5—atherosclerosis	3.4e-05	0.000196	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—F2—atherosclerosis	3.37e-05	0.000194	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—atherosclerosis	3.37e-05	0.000194	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LPL—atherosclerosis	3.34e-05	0.000192	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARA—atherosclerosis	3.31e-05	0.00019	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.3e-05	0.00019	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SERPINE1—atherosclerosis	3.3e-05	0.00019	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLA2G1B—atherosclerosis	3.27e-05	0.000188	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—atherosclerosis	3.26e-05	0.000187	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.24e-05	0.000186	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CG—atherosclerosis	3.23e-05	0.000186	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.22e-05	0.000185	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.21e-05	0.000184	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AGT—atherosclerosis	3.21e-05	0.000184	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.2e-05	0.000184	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CD36—atherosclerosis	3.17e-05	0.000182	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALOX5—atherosclerosis	3.16e-05	0.000182	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOS3—atherosclerosis	3.15e-05	0.000181	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—atherosclerosis	3.14e-05	0.00018	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAV1—atherosclerosis	3.11e-05	0.000179	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOA1—atherosclerosis	3.1e-05	0.000178	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INS—atherosclerosis	3.06e-05	0.000176	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL2—atherosclerosis	3.01e-05	0.000173	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—atherosclerosis	3.01e-05	0.000173	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—atherosclerosis	2.96e-05	0.00017	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARA—atherosclerosis	2.95e-05	0.00017	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.92e-05	0.000168	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AGT—atherosclerosis	2.86e-05	0.000164	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAMPT—atherosclerosis	2.84e-05	0.000163	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CG—atherosclerosis	2.83e-05	0.000163	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.82e-05	0.000162	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LIPC—atherosclerosis	2.82e-05	0.000162	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SERPINE1—atherosclerosis	2.81e-05	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOC3—atherosclerosis	2.8e-05	0.000161	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—atherosclerosis	2.8e-05	0.000161	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL8—atherosclerosis	2.8e-05	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LDLR—atherosclerosis	2.78e-05	0.00016	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAV1—atherosclerosis	2.77e-05	0.000159	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOA1—atherosclerosis	2.77e-05	0.000159	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARG—atherosclerosis	2.74e-05	0.000157	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CETP—atherosclerosis	2.72e-05	0.000156	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—atherosclerosis	2.7e-05	0.000155	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—INS—atherosclerosis	2.68e-05	0.000154	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOS3—atherosclerosis	2.68e-05	0.000154	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—atherosclerosis	2.66e-05	0.000153	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SCARB1—atherosclerosis	2.6e-05	0.00015	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.54e-05	0.000146	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—atherosclerosis	2.53e-05	0.000145	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CG—atherosclerosis	2.53e-05	0.000145	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NFKB1—atherosclerosis	2.5e-05	0.000144	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK8—atherosclerosis	2.46e-05	0.000141	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMGCR—atherosclerosis	2.46e-05	0.000141	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—atherosclerosis	2.46e-05	0.000141	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—atherosclerosis	2.45e-05	0.000141	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARG—atherosclerosis	2.44e-05	0.00014	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—INS—atherosclerosis	2.39e-05	0.000137	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL8—atherosclerosis	2.38e-05	0.000137	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NOS3—atherosclerosis	2.35e-05	0.000135	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—atherosclerosis	2.27e-05	0.000131	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—atherosclerosis	2.25e-05	0.000129	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.22e-05	0.000127	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCA1—atherosclerosis	2.19e-05	0.000126	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—atherosclerosis	2.19e-05	0.000126	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—atherosclerosis	2.15e-05	0.000124	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—atherosclerosis	2.15e-05	0.000124	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK3—atherosclerosis	2.15e-05	0.000123	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NFKB1—atherosclerosis	2.13e-05	0.000122	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NOS3—atherosclerosis	2.1e-05	0.000121	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK8—atherosclerosis	2.09e-05	0.00012	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFB1—atherosclerosis	2.08e-05	0.00012	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—atherosclerosis	1.93e-05	0.000111	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—atherosclerosis	1.92e-05	0.00011	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—atherosclerosis	1.91e-05	0.00011	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—atherosclerosis	1.88e-05	0.000108	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK3—atherosclerosis	1.83e-05	0.000105	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOB—atherosclerosis	1.8e-05	0.000104	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFB1—atherosclerosis	1.77e-05	0.000102	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—atherosclerosis	1.75e-05	0.000101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LPL—atherosclerosis	1.72e-05	9.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—atherosclerosis	1.68e-05	9.65e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CD36—atherosclerosis	1.63e-05	9.39e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—atherosclerosis	1.57e-05	9.03e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—atherosclerosis	1.55e-05	8.9e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARA—atherosclerosis	1.52e-05	8.73e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AGT—atherosclerosis	1.47e-05	8.46e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—atherosclerosis	1.45e-05	8.33e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—atherosclerosis	1.44e-05	8.29e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAV1—atherosclerosis	1.43e-05	8.21e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOA1—atherosclerosis	1.43e-05	8.19e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—atherosclerosis	1.34e-05	7.68e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CG—atherosclerosis	1.3e-05	7.48e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARG—atherosclerosis	1.26e-05	7.22e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—atherosclerosis	1.23e-05	7.08e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—INS—atherosclerosis	1.23e-05	7.08e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—atherosclerosis	1.13e-05	6.49e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—atherosclerosis	1.08e-05	6.22e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NOS3—atherosclerosis	1.08e-05	6.21e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—atherosclerosis	9.88e-06	5.68e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—atherosclerosis	9.64e-06	5.54e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—atherosclerosis	4.97e-06	2.85e-05	CbGpPWpGaD
